Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-26

Clinical Trial Update: Type 2 Diabetes Mellitus Prevention Ukraine [Phase 2]

View source ↗

Summary

Phase 2 trial update in Ukraine evaluating prevention of type 2 diabetes mellitus in individuals with impaired fasting glucose or impaired glucose tolerance (co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Komisarenko Institute of Endocrinology and Metobolism | Conditions: Impaired Fasting Glucose, Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED